Author:
Ghaidar Donya,Sippel Anna,Riemann-Lorenz Karin,Kofahl Christopher,Morrison Rebecca,Kleiter Ingo,Schmidt Stephan,Dettmers Christian,Schulz Holger,Heesen Christoph
Abstract
Abstract
Background
Managing multiple sclerosis (MS) includes different treatment approaches. Rehabilitation is a key strategy in MS for improving functioning, activity and participation. As part of a larger study on overall patient experiences with different treatment approaches, this study aims to give an overview of different patients’ experiences and perspectives on inpatient rehabilitation in MS.
Methods
We conducted problem-centered interviews in 50 persons with MS in Germany, of whom most had relapsing–remitting MS. We used the maximum variation sampling method during recruitment. Data were analyzed thematically.
Results
As a result of the analysis, three major themes were identified: 1) factors contributing to the decision-making concerning rehabilitation, 2) experience with the rehabilitation setting, 3) benefits of rehabilitation treatments. The treating physicians’ attitude had a major impact on the decision to either opt for rehabilitation or not. Setting goals prior to rehabilitation was given a high priority. Exchanging experiences with other persons with MS presented a major benefit from rehabilitation while for some being separated from regular daily life resulted in a more ambiguous attitude ranging from appreciation of escaping daily hassles to substantial behavioral change management.
Conclusion
Patients reported various experiences in the process of decision-making with regard to rehabilitation. Physicians´ advice, goal setting and the selection of the most suitable rehabilitation clinic were considered most relevant.
Funder
Roche Pharma AG
Universitätsklinikum Hamburg-Eppendorf (UKE)
Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. Thompson AJ, Baranzini SE, Geurts J, et al. Multiple sclerosis. The Lancet. 2018;391(10130):1622–36.
2. World Health Organization. Multiple Sclerosis International Federation. Atlas: multiple sclerosis resources in the world 2008. Geneva: World Health Organization; 2008.
3. Holstiege J, Steffen A, Goffrier B, et al. Epidemiologie der Multiplen Sklerose-eine populationsbasierte deutschlandweite Studie. www.versorgungsatlas.de. Versorgungsatlas-Report: 2017. p. 1–16. https://doi.org/10.20364/VA-17.09.
4. Ellenberger D, Flachenecker P, Haas J, et al. Is benign MS really benign? what a meaningful classification beyond the EDSS must take into consideration. Mult Scler Relat Disord. 2020;46: 102485.
5. Sorensen PS, Sellebjerg F, Hartung HP, et al. The apparently milder course of multiple sclerosis: changes in the diagnostic criteria, therapy and natural history. Brain. 2020;143(9):2637–52.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献